Jan Jacob Schuringa results 1
· Newest (Page 1/1, per page 25)
Author: Jan Jacob Schuringa ×Clear All Filters
Search Results
Acute myeloid leukaemia is an aggressive hematologic malignancy that remains exceedingly difficult to treat despite recent advancements. High expression of CD47 on leukemic blasts interacts with the inhibitory receptor SIRP-alpha (SIRP-α) on innate immune cells, resulting in a strong "don't eat me" signal. Therefore, identifying AML patients who could benefit from immune-targeted therapies is crucial SIRP-β2 is predominantly e...
Previous1Next